Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sean P. Cleary"'
Autor:
Roman O. Kowalchuk, Scott C. Lester, Rondell P. Graham, William S. Harmsen, Lizhi Zhang, Thorvardur R. Halfdanarson, Rory L. Smoot, Hunter C. Gits, Wen Wee Ma, Dawn Owen, Amit Mahipal, Robert C. Miller, Michelle A. Neben Wittich, Sean P. Cleary, Robert R. McWilliams, Michael G. Haddock, Christopher L. Hallemeier, Mark J. Truty, Kenneth W. Merrell
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundWe evaluated preoperative CA 19-9 levels in patients with resected pancreatic cancer to analyze whether they were predictive of clinical outcomes and could help select patients for additional therapy. We hypothesized that elevated CA 19-9 w
Externí odkaz:
https://doaj.org/article/b7f77653da604b9ba3c28f4b8f2a3572
Autor:
Kabir Mody, Sean P. Cleary
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Circulating tumor DNA (ctDNA) is released into circulation (blood) specifically from tumor cells undergoing metabolic secretion, apoptosis, or necrosis, carries tumor-specific genetic or epigenetic alterations. Technologies enabling clinical evaluati
Externí odkaz:
https://doaj.org/article/584904c3324b4bb381f66ec8d2b382f7
Autor:
Michelle A. Neben Wittich, Christopher L. Hallemeier, Kenneth W. Merrell, Lizhi Zhang, Scott C. Lester, Sean P. Cleary, Amit Mahipal, Thorvardur R. Halfdanarson, Michael G. Haddock, Rory L. Smoot, Roman O. Kowalchuk, Hunter C. Gits, William S. Harmsen, Rondell P. Graham, Mark J. Truty, Dawn Owen, Robert R. McWilliams, Wen Wee Ma, Robert C. Miller
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
BackgroundWe evaluated preoperative CA 19-9 levels in patients with resected pancreatic cancer to analyze whether they were predictive of clinical outcomes and could help select patients for additional therapy. We hypothesized that elevated CA 19-9 w